KPMG’s global chair for life sciences comments
Chris Stirling says: “For Britain it's the first tangible evidence of what being outside the jurisdiction of the single market, the CJEU and other EU legal structures means. Once it became clear after Lancaster House that these were UK red-lines, the EMA's relocation was inevitable.
“The EMA’s departure means we lose regulatory jobs of course, but it is also clear that the UK's domestic regulator the MHRA will need a major repositioning post-Brexit. Much of its day to day activity is in support of the EMA, and much of what the EMA does is relied on by the MHRA.
“For Amsterdam it's a windfall beyond just the regulatory jobs. We know that our clients consider being close to the EMA as an important consideration in location strategy, so the EMA location should attract private sector investment as a result.
“The Amsterdam decision may well have been influenced by staff retention issues, as it is close to London and a popular city for international business.
“The relocation does, however, open doors for the creation of a single UK agency for medicines, medical devices and veterinary medical products. Rapid advancements in science and technology over the last 10 years has fast out-paced European regulatory frameworks, with regulators and payers alike struggling to assess the true benefit of new innovations, such as curative therapies.
“The relocation could provide an opportunity to streamline and enhance the abundance of regulation in this area, to find better and cheaper ways of preventing, treating and curing disease.”
Notes to Editors:
Helen Jackson, corporate communications manager
+44 (0)118 373 1479
M: +44 (0)790 111 5649
KPMG Press office
Tel: +44 (0) 20 7694 8773
KPMG LLP, a UK limited liability partnership, operates from 22 offices across the UK with approximately 13,500 partners and staff. The UK firm recorded a revenue of £2.07 billion in the year ended 30 September 2016. KPMG is a global network of professional firms providing Audit, Tax, and Advisory services. It operates in 152 countries and has 189,000 professionals working in member firms around the world. The independent member firms of the KPMG network are affiliated with KPMG International Cooperative ("KPMG International"), a Swiss entity. Each KPMG firm is a legally distinct and separate entity and describes itself as such.